Amirhossein Mardi

6 ta ish

Tabriz University of Medical Sciences

1. Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

   Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi +12

   MaqolaOAOchiq kirish20223 iqtibos

   ABIABI:AkademIndex/2026.other.047821

2. Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies

   Amirreza Mehmandar‐Oskuie, Kasra Jahankhani, Arman Rostamlou +3

   Sharh maqola20233 iqtibos

   ABIABI:AkademIndex/2026.other.289211

3. Molecular mechanism of lncRNAs in pathogenesis and diagnosis of auto-immune diseases, with a special focus on lncRNA-based therapeutic approaches

   Amirreza Mehmandar‐Oskuie, Kasra Jahankhani, Arman Rostamlou +4

   Sharh maqola20233 iqtibos

   ABIABI:AkademIndex/2026.other.289212

4. The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies

   Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh +4

   Sharh maqolaOAOchiq kirish20232 iqtibos

   ABIABI:AkademIndex/2026.other.102935

5. lncRNA PVT1 silencing inhibits gastric cancer cells’ progression via enhancing chemosensitivity to paclitaxel

   Bahar Naseri, Nader Farsad-Akhtar, Amirhossein Mardi +4

   Maqola20242 iqtibos

   ABIABI:AkademIndex/2026.other.127113

6. Restoration of miR-648 overcomes 5-FU-resistance through targeting ET-1 in gastric cancer cells in-vitro

   Parsa Aliabadi, Maryam Sadri, Goli Siri +8

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.267333